The Claim
Daily supplementation with 10 mg or more of melatonin for at least 12 weeks is associated with significant reductions in systemic inflammatory markers, including interleukin-6 and tumor necrosis factor-alpha, likely mediated by the inhibition of nuclear factor-kB translocation.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking 10 milligrams or more of melatonin every day for at least three months may help lower your body's overall inflammation levels. This happens because the supplement might block a specific cellular switch that normally triggers inflammatory chemicals like IL-6 and TNF-alpha.
See the scientific wording
Long-term melatonin supplementation at daily doses of 10 mg or higher for 12 weeks or more is associated with significant reductions in systemic inflammatory markers, including interleukin-6 and tumor necrosis factor-alpha. Clinical evidence suggests that sustained high-dose interventions are necessary to effectively modulate inflammatory pathways, likely through inhibition of nuclear factor-kB translocation and subsequent suppression of pro-inflammatory mediator production.
Score breakdown, mechanism chain, raw evidence, ideal studies needed
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.